Company Overview
Beam Therapeutics is committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform that includes a suite of gene editing and delivery technologies and is in the process of building internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.
Position Overview:
Beam is seeking a passionate and motivated co-op student to join our expanding liver team from January through June 2025. The co-op will aid in advancing an early-stage liver program from discovery toward the clinic in a highly collaborative and fast-paced environment. The individual will be responsible for developing protein-based and biochemical assays for functional validation of base editing in vitro/in vivo to support liver drug discovery programs at Beam.
Responsibilities:
Qualifications: